133 related articles for article (PubMed ID: 19229287)
21. Magnetic field induced inhibition of human osteosarcoma cells treated with adriamycin.
Chakkalakal DA; Mollner TJ; Bogard MR; Fritz ED; Novak JR; McGuire MH
Cancer Biochem Biophys; 1999 Jul; 17(1-2):89-98. PubMed ID: 10738905
[TBL] [Abstract][Full Text] [Related]
22. Radiosensitization of breast cancer cells by TRAIL-endostatin-targeting gene therapy.
Li YB; Guo CX; Wang ZC; Dong LH; Guan F; Liu Y; Wang HF; Sun ZW; Gong SL
Neoplasma; 2013; 60(6):613-9. PubMed ID: 23906295
[TBL] [Abstract][Full Text] [Related]
23. Profiling of chemonaive osteosarcoma and paired-normal cells identifies EBF2 as a mediator of osteoprotegerin inhibition to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.
Patiño-García A; Zalacain M; Folio C; Zandueta C; Sierrasesúmaga L; San Julián M; Toledo G; De Las Rivas J; Lecanda F
Clin Cancer Res; 2009 Aug; 15(16):5082-91. PubMed ID: 19671856
[TBL] [Abstract][Full Text] [Related]
24. The genus Bifidobacterium for cancer gene therapy.
Fujimori M; Amano J; Taniguchi S
Curr Opin Drug Discov Devel; 2002 Mar; 5(2):200-3. PubMed ID: 11926126
[TBL] [Abstract][Full Text] [Related]
25. Cotreatment with apicidin overcomes TRAIL resistance via inhibition of Bcr-Abl signaling pathway in K562 leukemia cells.
Park SJ; Kim MJ; Kim HB; Sohn HY; Bae JH; Kang CD; Kim SH
Exp Cell Res; 2009 Jul; 315(11):1809-18. PubMed ID: 19268463
[TBL] [Abstract][Full Text] [Related]
26. PNAS-4, a novel pro-apoptotic gene, can potentiate antineoplastic effects of cisplatin.
Yuan Z; Yan F; Wang YS; Liu HY; Gou LT; Zhao XY; Lai ST; Deng HX; Li J; Ding ZY; Xiong SQ; Kan B; Mao YQ; Chen LJ; Wei YQ; Zhao X
Cancer Chemother Pharmacol; 2009 Dec; 65(1):13-25. PubMed ID: 19387645
[TBL] [Abstract][Full Text] [Related]
27. Triazine-modified dendrimer for efficient TRAIL gene therapy in osteosarcoma.
Wang Y; Li L; Shao N; Hu Z; Chen H; Xu L; Wang C; Cheng Y; Xiao J
Acta Biomater; 2015 Apr; 17():115-24. PubMed ID: 25595474
[TBL] [Abstract][Full Text] [Related]
28. A caspase-6 and anti-HER2 antibody chimeric tumor-targeted proapoptotic molecule decreased metastasis of human osteosarcoma.
Wang LF; Zhou Y; Xu YM; Qiu XC; Zhou BG; Wang F; Long H; Chen X; Yang TT; Ma BA; Fan QY; Yang AG
Cancer Invest; 2009 Aug; 27(7):774-80. PubMed ID: 19488908
[TBL] [Abstract][Full Text] [Related]
29. Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy.
Menon LG; Kelly K; Yang HW; Kim SK; Black PM; Carroll RS
Stem Cells; 2009 Sep; 27(9):2320-30. PubMed ID: 19544410
[TBL] [Abstract][Full Text] [Related]
30. Linking antibody Fc domain to endostatin significantly improves endostatin half-life and efficacy.
Lee TY; Tjin Tham Sjin RM; Movahedi S; Ahmed B; Pravda EA; Lo KM; Gillies SD; Folkman J; Javaherian K
Clin Cancer Res; 2008 Mar; 14(5):1487-93. PubMed ID: 18316573
[TBL] [Abstract][Full Text] [Related]
31. Trimeric coiled-coil domain of human pulmonary surfactant protein D enhances zinc-binding ability and biologic activity of soluble TRAIL.
Wu X; Li P; Qian C; Li O; Zhou Y
Mol Immunol; 2009 Jul; 46(11-12):2381-8. PubMed ID: 19481806
[TBL] [Abstract][Full Text] [Related]
32. Sugar transport systems of Bifidobacterium longum NCC2705.
Parche S; Amon J; Jankovic I; Rezzonico E; Beleut M; Barutçu H; Schendel I; Eddy MP; Burkovski A; Arigoni F; Titgemeyer F
J Mol Microbiol Biotechnol; 2007; 12(1-2):9-19. PubMed ID: 17183207
[TBL] [Abstract][Full Text] [Related]
33. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
Li X; Ding L; Xu Y; Wang Y; Ping Q
Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
[TBL] [Abstract][Full Text] [Related]
34. Construction, characterization and exemplificative application of bioluminescent Bifidobacterium longum biovar longum.
Guglielmetti S; Ciranna A; Mora D; Parini C; Karp M
Int J Food Microbiol; 2008 Jun; 124(3):285-90. PubMed ID: 18471916
[TBL] [Abstract][Full Text] [Related]
35. Molecular characterization of Bifidobacterium longum biovar longum NAL8 plasmids and construction of a novel replicon screening system.
Guglielmetti S; Karp M; Mora D; Tamagnini I; Parini C
Appl Microbiol Biotechnol; 2007 Apr; 74(5):1053-61. PubMed ID: 17151871
[TBL] [Abstract][Full Text] [Related]
36. Trichostatin A sensitizes human ovarian cancer cells to TRAIL-induced apoptosis by down-regulation of c-FLIPL via inhibition of EGFR pathway.
Park SJ; Kim MJ; Kim HB; Sohn HY; Bae JH; Kang CD; Kim SH
Biochem Pharmacol; 2009 Apr; 77(8):1328-36. PubMed ID: 19426671
[TBL] [Abstract][Full Text] [Related]
37. Enhancement of antitumor properties of rhTRAIL by affinity increase toward its death receptors.
Reis CR; van der Sloot AM; Szegezdi E; Natoni A; Tur V; Cool RH; Samali A; Serrano L; Quax WJ
Biochemistry; 2009 Mar; 48(10):2180-91. PubMed ID: 19236007
[TBL] [Abstract][Full Text] [Related]
38. A functional analysis of the Bifidobacterium longum cscA and scrP genes in sucrose utilization.
Kullin B; Abratt VR; Reid SJ
Appl Microbiol Biotechnol; 2006 Oct; 72(5):975-81. PubMed ID: 16523284
[TBL] [Abstract][Full Text] [Related]
39. Recombinant
Bi Z; Cui E; Yao Y; Chang X; Wang X; Zhang Y; Xu GX; Zhuang H; Hua ZC
Front Microbiol; 2022; 13():927277. PubMed ID: 35847065
[No Abstract] [Full Text] [Related]
40. TRAIL-induced apoptosis of FHIT-negative lung cancer cells is inhibited by FHIT re-expression.
Mirandola P; Gobbi G; Sponzilli I; Malinverno C; Cavazzoni A; Alfieri R; Petronini PG; Vitale M
J Cell Physiol; 2009 Aug; 220(2):492-8. PubMed ID: 19418484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]